Regulatory and Drug Development Consultancy
Drug Delivery
Information
SGS supports numerous biotech companies to answer the complex requirements of health authorities and also successfully perform IND and CTA submissions.
With our in-house experts working as a team and as not individual consultants, we can efficiently help you move your drug candidate from non-clinical data through to patient trials, including:
- Early phase development strategy & tactics
- Validation of strategy with Regulators
- Development and redaction of official health authorities’ trial documents (FDA, EMA…)
- Scientific/Medical/Statistical input
- Modelling & simulations
